Pediatric immunity refers to the complex and dynamic defense mechanisms that protect children from infections and maintain overall health. The immune system in children undergoes developmental changes from birth through adolescence, adapting to confront diverse pathogens while avoiding inappropriate responses to harmless substances. Neonatal immunity is initially influenced by maternal antibodies transferred during pregnancy and breastfeeding, providing passive protection. As infants grow, their immune system matures, and they develop active immunity through vaccination and exposure to pathogens. Pediatric immunity includes innate and adaptive components, involving various immune cells, antibodies, and cytokines. Early exposure to microbes helps shape the immune system's ability to distinguish between self and non-self, fostering tolerance. Vaccination plays a crucial role in pediatric immunity, preventing severe infectious diseases. Factors such as nutrition, genetics, and environmental exposures also impact immune development in children. Understanding pediatric immunity is essential for optimizing vaccination strategies, managing infections, and promoting overall well-being in pediatric populations. Ongoing research continues to enhance our knowledge of pediatric immune responses and inform strategies to improve child health.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia